Millennium Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Millennium Management’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-58,579	Closed	-$5K	–	7436
2022 Q4	$5K	Buy	58,579 +33,227	+131%	+$4.22K	﹤0.01%	6321
2022 Q3	$3K	Buy	25,352 +6,657	+36%	+$1.4K	﹤0.01%	6906
2022 Q2	$5K	Buy	+18,695	New	+$4.84K	﹤0.01%	6792
2020 Q4	–	Sell	-10,267	Closed	-$20K	–	5727
2020 Q3	$20K	Buy	+10,267	New	+$23.6K	﹤0.01%	4350

Other funds holding STAB

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Tucker Asset Management Littleton, Colorado $405M AUM 27.41% 1-Year Est. Return

Millennium Management's STAB Position: Q1 2023 in Review

Millennium Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 58,579 shares — an estimated $5K sold.

Millennium Management first reported a position in STAB in Q3 2020 and held it in 4 quarters. The position peaked at $20K in Q3 2020. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

Millennium Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 58,579 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $5K.
Millennium Management first reported a position in Statera Biopharma, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Millennium Management's Statera Biopharma, Inc. Common Stock position peaked at $20K in Q3 2020.
4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.